TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $38,449,215 | -5.0% | 1,547,875 | -42.5% | 0.07% | -24.7% |
| Q1 2023 | $40,456,442 | +12.3% | 2,689,923 | -11.6% | 0.09% | -36.0% |
| Q4 2022 | $36,015,453 | +270.3% | 3,044,417 | +85.3% | 0.14% | +348.4% |
| Q3 2022 | $9,725,000 | +29.5% | 1,642,675 | -7.0% | 0.03% | +55.0% |
| Q2 2022 | $7,511,000 | -56.1% | 1,767,130 | -1.7% | 0.02% | -41.2% |
| Q1 2022 | $17,099,000 | -51.8% | 1,798,010 | -3.8% | 0.03% | -48.5% |
| Q4 2021 | $35,498,000 | -73.8% | 1,868,301 | -54.1% | 0.07% | -71.2% |
| Q3 2021 | $135,393,000 | -14.5% | 4,068,301 | -0.3% | 0.23% | -2.1% |
| Q2 2021 | $158,360,000 | -19.7% | 4,082,495 | -0.2% | 0.23% | -20.1% |
| Q1 2021 | $197,171,000 | -7.1% | 4,090,691 | +0.3% | 0.29% | -15.1% |
| Q4 2020 | $212,146,000 | +185.7% | 4,078,158 | +47.0% | 0.34% | +151.8% |
| Q3 2020 | $74,259,000 | +68.3% | 2,775,000 | +22.5% | 0.14% | +22.3% |
| Q2 2020 | $44,122,000 | +186.5% | 2,265,000 | +44.7% | 0.11% | +69.7% |
| Q1 2020 | $15,400,000 | +38.7% | 1,565,000 | +56.5% | 0.07% | +61.0% |
| Q4 2019 | $11,100,000 | – | 1,000,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
| RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
| Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
| Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
| Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
| Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
| ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
| 683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
| Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |